Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) EBIAT (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of EBIAT data on record, last reported at -$2.5 million in Q4 2019.

  • For Q4 2019, EBIAT fell 26.4% year-over-year to -$2.5 million; the TTM value through Dec 2019 reached -$10.6 million, down 85.72%, while the annual FY2024 figure was -$24.4 million, 25.9% down from the prior year.
  • EBIAT reached -$2.5 million in Q4 2019 per DMAC's latest filing, down from -$2.4 million in the prior quarter.
  • Across five years, EBIAT topped out at -$650000.0 in Q1 2018 and bottomed at -$3.3 million in Q1 2019.